ACYW135 group meningococcal polysaccharide vaccine
Indication
This product is only used to prevent epidemic cerebrospinal meningitis caused by groups A, C, Y and W135 of Neisseria meningitidis
Precautions
1. It is contraindicated for patients with epilepsy, convulsions, brain diseases and a history of allergies; 2. It is contraindicated for patients with kidney disease, heart disease and active tuberculosis; 3. It is contraindicated for patients with acute infectious diseases and fever.
Packaging Specification
After reconstitution, each bottle contains 0.5 ml. Each human dose is 0.5 ml, containing 50 μg of group A, group C, group Y and group W135 meningococcal capsular polysaccharides.
Manufacturer
Yuxi Walvax Biotechnology Co., Ltd.
-
Founded in:
2005-03-04 -
Address:
No. 83, Dongfeng South Road, Yuxi High-tech Zone, Yunnan Province -
Tax NO.:
91530400770492152K -
Registered Funds:
1.387366389 yuan -
Website:
-
Email: